1. Home
  2. ETS vs CMMB Comparison

ETS vs CMMB Comparison

Compare ETS & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

N/A

Current Price

$0.64

Market Cap

10.0M

Sector

Industrials

ML Signal

N/A

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

N/A

Current Price

$1.48

Market Cap

11.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ETS
CMMB
Founded
2020
2004
Country
United States
Israel
Employees
26
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
11.2M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ETS
CMMB
Price
$0.64
$1.48
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
25.6K
36.0K
Earning Date
04-13-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
101.67
EPS
N/A
0.04
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$37.25
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$0.87
52 Week High
$1.21
$3.86

Technical Indicators

Market Signals
Indicator
ETS
CMMB
Relative Strength Index (RSI) 49.20 38.28
Support Level $0.49 $1.41
Resistance Level $0.67 $1.64
Average True Range (ATR) 0.06 0.10
MACD -0.01 -0.02
Stochastic Oscillator 51.16 14.06

Price Performance

Historical Comparison
ETS
CMMB

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: